PEDS-PLAN – Pediatric Precision Laboratory Advanced Neuroblastoma Therapy A Study Using Molecular Guided Therapy with Induction Chemotherapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma

Grant

Date/time Interval

  • November 20, 2017 - November 19, 2022
  • Awarded By

    Total Award Amount

  • 15000.00
  • Direct Costs

  • 11028.00
  • Sponsor Award Id

  • Contributor

  • Elizabeth Alva   Principal Investigator  
  • Emily Johnston   Investigator  
  • Jamie Aye   Investigator  
  • Kimberly Whelan M.D.   Investigator  
  • Wayne Liang   Investigator